Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIMINI-Pilot: Ranolazine in Acute Myocardial Ischemia
NCT01797484Phase 3Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Aug 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ranolazine in acute myocardial ischemia, sponsored by University Medical Center Hamburg-Eppendorf. Started Aug 2013; status: completed.
02
Drugs
ranolazine
03
Conditions
acute myocardial ischemia
Beyond the preview
Go deeper on NCT01797484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01797484.